Overall, people on semaglutide ate 24% to 30% fewer calories, the study found.People taking semaglutide also lost an average 15% of their body weight during the 60-week trial, compared to a little over 3% for those on placebo.Interestingly, these results occurred even though participants hunger, appetite and food preoccupation wound up at about the same level from week 40 on, researchers said."This study highlights an important distinction between peoples perceptions of their appetite and how they actually eat," senior researcher Thomas Wadden, a professor of psychology in psychiatry at Penn Medicine, said in a news release."People taking semaglutide for weight loss often notice dramatic reductions in hunger and food noise when they begin this treatment
These results have generated considerable scientific interest, though retatrutide has not yet received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) for clinical use in the UK or Europe at the time of writing
Normal minor effects include mild soreness or a small bruise at the IV site, temporary chills or feeling cold, and short-lived fatigue as your body rebalances fluid and nutrient levels
KLOW Peptide Dosage: Chart & Reconstitution Guide Overview KLOW Peptide Dosage: Chart & Reconstitution Guide
